SCHEMBL24896258

SCHEMBL24896258

COc1nccc2cc(C(=O)O)n(C)c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
MCL1 Q07820 2/20 0.43
SRD5A2 P31213 2/20 0.41
SRD5A1 P18405 1/20 0.41
GPR35 Q9HC97 1/20 0.40
ACSS2 Q9NR19 1/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GFER P55789 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
CCR2 P41597 1/20 0.34
DHODH Q02127 1/20 0.34
PHGDH O43175 1/20 0.34
KDM6B O15054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30220608 0.87 L3MBTL1 (0.50) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24896464 0.82 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24896374 0.80 MCL1 (0.46) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL20504453 0.79 MCL1 (0.45) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24896316 0.77 MCL1 (0.43) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24896576 0.77 MCL1 (0.43) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24582707 0.77 HSD17B10 (0.48) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25003509 0.76 ALDH1A1 (0.38) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24896381 0.76 GRM4 (0.38) L3MBTL1MAPTPHGDH
SCHEMBL24896365 0.75 HSD17B10 (0.42) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-09 US disclosed
WO-2023287704-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2023-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 KDM4E 1723/4885ALDH1A1 2558/4885HPGD 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.